Sharma Sonam, Hertan Lauren, Jones Joshua
Department of Radiation Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA.
Department of Radiation Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA.
Semin Oncol. 2014 Dec;41(6):751-63. doi: 10.1053/j.seminoncol.2014.09.021. Epub 2014 Oct 7.
For nearly 100 years, palliative radiotherapy has been a time-efficient, effective treatment for patients with metastatic or advanced cancer in any area where local tumors are causing symptoms. Short courses including a single fraction of radiotherapy may be effective for symptom relief with minimal side effects and maximization of convenience for patient and family. With recent advances in imaging, surgery, and other local therapies as well as systemic cancer therapies, palliative radiotherapy has been used frequently in patients who may not yet have symptoms of advanced or metastatic cancer. In this setting, more prolonged radiotherapy courses and advanced radiotherapy techniques including intensity-modulated radiotherapy (IMRT) or stereotactic radiotherapy (SRT) may be useful in obtaining local control and durable palliative responses. This review will explore the use of radiotherapy across the spectrum of patients with advanced and metastatic cancer and delineate an updated, rational approach for the use of palliative radiotherapy that incorporates symptoms, prognosis, and other factors into the delivery of palliative radiotherapy.
近100年来,姑息性放疗一直是一种高效的治疗方法,适用于任何局部肿瘤引发症状的转移性或晚期癌症患者。短疗程放疗,包括单次分割放疗,可能对缓解症状有效,副作用最小,且极大地方便了患者及其家属。随着影像学、手术及其他局部治疗以及全身性癌症治疗的最新进展,姑息性放疗已频繁应用于可能尚未出现晚期或转移性癌症症状的患者。在这种情况下,更长疗程的放疗以及包括调强放疗(IMRT)或立体定向放疗(SRT)在内的先进放疗技术,可能有助于实现局部控制并获得持久的姑息治疗效果。本综述将探讨放疗在晚期和转移性癌症患者中的应用,并阐述一种更新的、合理的姑息性放疗使用方法,该方法将症状、预后及其他因素纳入姑息性放疗的实施过程中。